# CLOVER HEALTH INVESTMENTS CO (CLOV)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CLOV/

- Reporting holders: 8
- Reported value: $1.4M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.2M | 267,508 | 0.0% | 16 |
| [Silverleafe Capital Partners, LLC](https://holderbook.com/funds/1535611-silverleafe-capital-partners-llc/) | $172.4K | 40,000 | 0.0% | 9 |
| [Everhart Financial Group, Inc.](https://holderbook.com/funds/1852858-everhart-financial-group-inc/) | $54.1K | 12,546 | 0.0% | 3 |
| [Ballew Advisors, Inc](https://holderbook.com/funds/1729096-ballew-advisors-inc/) | $43.8K | 10,000 | 0.0% | 1 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $17.1K | 3,978 | 0.0% | 1 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $621 | 144 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $556 | 129 | 0.0% | 4 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $431 | 100 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 8 | $1.4M |
| Q2 2026 | 232 | $954.4M |
| Q1 2026 | 209 | $242.3M |
| Q4 2025 | 195 | $332.1M |
| Q3 2025 | 203 | $464.0M |
| Q2 2025 | 200 | $435.6M |
| Q1 2025 | 201 | $415.0M |
| Q4 2024 | 181 | $333.9M |
| Q3 2024 | 162 | $262.3M |
| Q2 2024 | 128 | $96.6M |
| Q1 2024 | 137 | $76.6M |
| Q4 2023 | 146 | $98.4M |